{"id":"https://openalex.org/W2990765700","doi":"https://doi.org/10.1182/blood-2019-124659","title":"Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation: Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors","display_name":"Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation: Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2990765700","doi":"https://doi.org/10.1182/blood-2019-124659","mag":"2990765700"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-124659","doi":"https://doi.org/10.1182/blood-2019-124659","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-124659","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082846328","display_name":"Cornelis N. de Jong","orcid":"https://orcid.org/0000-0003-2054-0752","observed_orcids":["https://orcid.org/0000-0003-2054-0752"]},"institutions":[{"id":"https://openalex.org/I4210124011","display_name":"Ziekenhuis Gelderse Vallei","ror":"https://ror.org/03862t386","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210124011"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Cornelis N. De Jong","raw_affiliation_strings":["Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands","Department of Internal Medicine, Gelderse Vallei Hospital, Ede, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands","institution_ids":["https://openalex.org/I4210149908"]},{"raw_affiliation_string":"Department of Internal Medicine, Gelderse Vallei Hospital, Ede, Netherlands","institution_ids":["https://openalex.org/I4210124011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048440121","display_name":"Ellen Meijer","orcid":"https://orcid.org/0000-0002-4317-6554","observed_orcids":["https://orcid.org/0000-0002-4317-6554"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ellen Meijer","raw_affiliation_strings":["Department of Hematology, Amsterdam UMC, location VU, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Amsterdam UMC, location VU, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I865915315","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090780331","display_name":"Katerina Bakunina","orcid":"https://orcid.org/0000-0003-3737-7971","observed_orcids":["https://orcid.org/0000-0003-3737-7971"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Katerina Bakunina","raw_affiliation_strings":["HOVON Data Center, Erasmus Medical Center, Rotterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HOVON Data Center, Erasmus Medical Center, Rotterdam, Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049097971","display_name":"Erfan Nur","orcid":"https://orcid.org/0000-0002-7069-930X","observed_orcids":["https://orcid.org/0000-0002-7069-930X"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Erfan Nur","raw_affiliation_strings":["Department of Hematology, Amsterdam UMC, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Amsterdam UMC, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210151833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111665123","display_name":"Marinus van Marwijk Kooij","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146510","display_name":"Isala","ror":"https://ror.org/046a2wj10","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210146510"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marinus van Marwijk Kooij","raw_affiliation_strings":["Department of Hematology, Isala Clinics, Zwolle, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Isala Clinics, Zwolle, Netherlands","institution_ids":["https://openalex.org/I4210146510"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068744991","display_name":"Marco R. de Groot","orcid":"https://orcid.org/0000-0001-6933-607X","observed_orcids":["https://orcid.org/0000-0001-6933-607X"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marco R. de Groot","raw_affiliation_strings":["University Medical Center Groningen, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center Groningen, Groningen, Netherlands","institution_ids":["https://openalex.org/I1334415907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021274228","display_name":"Michel van Gelder","orcid":"https://orcid.org/0000-0001-8698-4351","observed_orcids":["https://orcid.org/0000-0001-8698-4351"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Michel van Gelder","raw_affiliation_strings":["Department of Hematology, Maastricht University Medical Center, Maastricht, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Maastricht University Medical Center, Maastricht, Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086668079","display_name":"Johan A. Maertens","orcid":"https://orcid.org/0000-0003-4257-5980","observed_orcids":["https://orcid.org/0000-0003-4257-5980"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Johan A. Maertens","raw_affiliation_strings":["University Hospital Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056738351","display_name":"Jurgen H. E. Kuball","orcid":"https://orcid.org/0000-0002-3914-7806","observed_orcids":["https://orcid.org/0000-0002-3914-7806"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jurgen H.E. Kuball","raw_affiliation_strings":["Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054397552","display_name":"Dries Deeren","orcid":"https://orcid.org/0000-0001-9599-2142","observed_orcids":["https://orcid.org/0000-0001-9599-2142"]},"institutions":[{"id":"https://openalex.org/I4210144110","display_name":"AZ Delta","ror":"https://ror.org/04b0her22","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210144110"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Dries Deeren","raw_affiliation_strings":["Algemeen Ziekenhuis Delta, Roeselare, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Algemeen Ziekenhuis Delta, Roeselare, Belgium","institution_ids":["https://openalex.org/I4210144110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012101669","display_name":"Bronno van der Holt","orcid":"https://orcid.org/0000-0001-6414-2671","observed_orcids":["https://orcid.org/0000-0001-6414-2671"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Bronno van der Holt","raw_affiliation_strings":["Department of Hematology, HOVON Data Center, Erasmuc MC Cancer Institute, Rotterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, HOVON Data Center, Erasmuc MC Cancer Institute, Rotterdam, Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066560929","display_name":"Jan J. Cornelissen","orcid":"https://orcid.org/0000-0002-1864-4598","observed_orcids":["https://orcid.org/0000-0002-1864-4598"]},"institutions":[{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jan J Cornelissen","raw_affiliation_strings":["Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands","institution_ids":["https://openalex.org/I4210149908"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064285955","display_name":"Annoek E. C. Broers","orcid":"https://orcid.org/0000-0003-0118-0966","observed_orcids":["https://orcid.org/0000-0003-0118-0966"]},"institutions":[{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Annoek E.C. Broers","raw_affiliation_strings":["Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands","institution_ids":["https://openalex.org/I4210149908"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"1","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/post-transplant-cyclophosphamide","display_name":"post-transplant cyclophosphamide","score":0.9810000061988831},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9940000176429749},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9100000262260437},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.7879999876022339},{"id":"https://openalex.org/keywords/mycophenolic-acid","display_name":"mycophenolic acid","score":0.9710000157356262},{"id":"https://openalex.org/keywords/graft-versus-leukemia-effect","display_name":"graft-versus-leukemia effect","score":0.8320000171661377},{"id":"https://openalex.org/keywords/graft-versus-host-disease-free-survival","display_name":"graft-versus-host disease-free survival","score":0.7110000252723694},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.753000020980835},{"id":"https://openalex.org/keywords/matched-unrelated-donor","display_name":"matched unrelated donor","score":0.6330000162124634},{"id":"https://openalex.org/keywords/matched-related-donor","display_name":"matched related donor","score":0.9620000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7803980112075806},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.6986154317855835},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6374251842498779},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.574247419834137},{"id":"https://openalex.org/C2779972918","wikidata":"https://www.wikidata.org/wiki/Q1194520","display_name":"Graft-versus-host disease","level":3,"score":0.5120394825935364},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.48976850509643555},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.472852498292923},{"id":"https://openalex.org/C2778033501","wikidata":"https://www.wikidata.org/wiki/Q420553","display_name":"Mycophenolic acid","level":3,"score":0.45685580372810364},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.44648104906082153},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.44387513399124146},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43324556946754456},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.4311390519142151},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3784891664981842},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3238431215286255},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23102882504463196}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1182/blood-2019-124659","doi":"https://doi.org/10.1182/blood-2019-124659","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-124659","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/a8fb85c9-1e16-40eb-915d-65d48407761a","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/posttransplantation-cyclophosphamide-after-allogeneic-hematopoietic-stem-cell-transplantation-results-of-the-prospective-randomized-hovon96-trial-in-recipients-of-matched-related-and-unrelated-donors(a8fb85c9-1e16-40eb-915d-65d48407761a).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 134(1). American Society of Hematology","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/59d692f0-61c7-43e8-9d7c-6503d4f7ac20","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/59d692f0-61c7-43e8-9d7c-6503d4f7ac20","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"de Jong, C N, Meijer, E, Bakunina, K, Nur, E, van Marwijk Kooij, M, de Groot, M R, van Gelder, M, Maertens, J A, Kuball, J H E, Deeren, D, van der Holt, B, Cornelissen, J J & Broers, A E C 2019, 'Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation: Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors', Blood, vol. 134, no. 1, pp. 1. https://doi.org/10.1182/blood-2019-124659","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4211182690","https://openalex.org/W3214539436","https://openalex.org/W2982826570","https://openalex.org/W2918037464","https://openalex.org/W4407095461","https://openalex.org/W2560729638","https://openalex.org/W4415669615","https://openalex.org/W3103576165","https://openalex.org/W3217055899","https://openalex.org/W4389235857"],"abstract_inverted_index":{"Background":[0],"Allogeneic":[1],"hematopoietic":[2],"stem":[3],"cell":[4],"transplantation":[5,84,347],"(alloHSCT)":[6],"has":[7],"been":[8],"established":[9],"as":[10,113,527],"a":[11,141,186,229,235,499,517],"powerful":[12],"treatment":[13,355],"modality":[14],"for":[15,205,243],"patients":[16,183],"with":[17,27,56,75,94,146,157,185,228,256,522],"hematological":[18],"malignancies.":[19],"The":[20,302,357,416,438,449,466,477],"graft-versus-leukemia":[21],"effect,":[22],"however,":[23],"is":[24,89,124],"strongly":[25],"associated":[26,93,156],"the":[28,109,118,128,150,206,353,457,463,531],"occurrence":[29],"of":[30,59,97,111,120,196,232,248,267,277,315,325,329,364,373,392,419,427,441,452,469,483,494,533,607],"graft-versus-host":[31],"disease":[32],"(GVHD)":[33],"and":[34,63,80,92,100,148,167,178,222,253,275,310,327,336,346,384,409,446,474,488,505,546,555,562,569,575,583,590],"subsequent":[35],"transplant-related":[36],"mortality":[37],"(TRM).":[38],"Several":[39],"strategies":[40],"are":[41],"applied":[42],"in":[43,78,117,308,313,323,371,425,456,462,498,502,513,530],"order":[44],"to":[45,115,139,165,281,399],"prevent":[46],"GVHD":[47,99,368,395,422,507,528],"following":[48,377,414,431],"T-cell":[49],"replete":[50],"alloHSCT":[51,123],"including":[52],"conventional":[53],"immunosuppression":[54,520],"(CIS)":[55],"post-transplant":[57,68],"administration":[58],"cyclosporine":[60],"A":[61,265],"(CyA)":[62],"mycophenolic":[64],"acid":[65],"(MA),":[66],"or":[67,72,190,609],"cyclophosphamide":[69,249],"(PT-Cy)":[70],"either":[71],"not":[73],"combined":[74,255],"CIS.":[76,415],"Studies":[77],"haplo-":[79],"HLA":[81,121],"matched":[82,122,187,198,306,311],"donor":[83,189,200,303],"have":[85],"shown":[86],"that":[87],"PT-Cy":[88,112,142,153,244,378,432,464,496,523],"well":[90],"tolerated":[91],"low":[95],"rates":[96],"severe":[98,406,503],"TRM.":[101],"However,":[102],"evidence":[103],"from":[104,258,320],"randomized":[105,204,242,271],"clinical":[106],"trials":[107],"on":[108,250,603],"efficacy":[110],"compared":[114],"CIS":[116,147,207,274,374,428,458],"setting":[119,532],"scarce.":[125],"Aims":[126],"In":[127,390],"present":[129],"prospective":[130],"randomized,":[131],"multicenter,":[132],"phase":[133],"III":[134],"trial":[135],"we":[136],"set":[137],"out":[138,195],"compare":[140],"based":[143],"immunosuppressive":[144],"regimen":[145,208,521],"address":[149],"question":[151],"whether":[152],"would":[154],"be":[155,525],"improved":[158,514],"GVHD-free/relapse-free":[159],"survival":[160,172,176],"(GRFS).":[161],"Endpoints":[162],"included":[163],"time":[164],"acute":[166,367,394,504],"chronic":[168,420,506],"GVHD,":[169],"progression":[170],"free":[171],"(PFS),":[173],"GRFS,":[174],"overall":[175],"(OS),":[177],"adverse":[179],"events.":[180],"Methods":[181],"Hematological":[182],"(pts)":[184],"related":[188,307],"at":[191,361],"least":[192],"an":[193,604],"8":[194,197],"unrelated":[199,312],"were":[201,295,318,349,412],"included.":[202],"Pts":[203,241],"received":[209,245,299],"CyA":[210,257],"twice":[211,226],"daily":[212,227],"until":[213,219,237,261],"day":[214,220,236,238,251,259,262],"+120":[215],"followed":[216],"by":[217],"tapering":[218],"+180":[221],"MA":[223],"16":[224],"mg/kg":[225,247],"maximum":[230],"dose":[231],"2160":[233],"mg":[234],"84":[239],"post-transplant.":[240],"50":[246],"+3":[252],"+4":[254],"+5":[260],"+70.":[263],"Results":[264],"total":[266],"160":[268],"pts":[269,298,326],"was":[270,289,305,369,396,423,443,454,471,485],"1:2":[272],"between":[273,352],"PT-Cy,":[276,393],"whom":[278],"94%":[279],"proceeded":[280],"transplant":[282],"(52":[283],"versus":[284,375,388,429,460],"99":[285],"pts).":[286],"Median":[287],"age":[288],"58":[290],"years":[291],"(range:":[292,334,342],"20-70),":[293],"66%":[294],"male.":[296],"Two":[297],"myeloablative":[300],"conditioning.":[301],"type":[304],"31%":[309],"69%":[314,472],"pts.":[316],"Transplants":[317],"derived":[319],"peripheral":[321],"blood":[322],"97%":[324],"consisted":[328],"median":[330,337],"6.14x106/kg":[331],"CD34+":[332],"cells/kg":[333],"1.36-19.4)":[335],"230x106/kg":[338],"CD3+":[339],"T":[340],"cells":[341],"0-519).":[343],"Baseline":[344],"patient":[345],"characteristics":[348],"equally":[350],"distributed":[351],"two":[354],"arms.":[356],"cumulative":[358],"incidence":[359],"(CI)":[360],"six":[362],"months":[363],"grade":[365,385],"II-IV":[366],"48%":[370],"recipients":[372,391,426],"32%":[376,461],"(SHR":[379,433],"0.52,":[380],"95%CI":[381,435],"0.31-0.87,":[382],"p=0.014),":[383],"III-IV":[386],"12%":[387],"6%.":[389],"generally":[397],"limited":[398],"stage":[400],"1":[401],"skin":[402,407],"involvement,":[403],"whereas":[404],"more":[405,518],"involvement":[408,411],"bowel":[410],"observed":[413],"two-year":[417],"CI":[418,451],"extensive":[421],"50%":[424],"19%":[430],"0.38,":[434],"0.21-0.67,":[436],"p=0.001).":[437],"three-year":[439,450,467],"estimate":[440,468,479],"PFS":[442],"60%":[444],"(44%-73%)":[445],"58%":[447],"(46%-67%).":[448],"progression/relapse":[453],"26%":[455],"arm":[459],"arm.":[465],"OS":[470],"(53%-80%)":[473],"63%":[475],"(52%-73%).":[476],"one-year":[478],"(95%":[480],"confidence":[481],"interval)":[482],"GRFS":[484],"22%":[486],"(12%-34%)":[487],"45%":[489],"(35%-55%),":[490],"respectively.":[491],"Conclusion":[492],"Use":[493],"high-dose":[495],"results":[497],"significant":[500],"reduction":[501],"without":[508],"affecting":[509],"relapse,":[510],"thereby":[511],"resulting":[512],"GRFS.":[515],"Hence,":[516],"intensified":[519],"might":[524],"preferred":[526],"prophylaxis":[529],"RIC":[534],"alloHSCT.":[535],"Figure":[536],"Disclosures":[537],"Nur:":[538],"Novartis":[539],"Pharmaceuticals:":[540],"Consultancy.":[541],"Maertens:Cidara:":[542],"Other:":[543,551,559,566,573,580,587],"Personal":[544,560,567,581,588],"fees":[545,554,561,568,582,589],"non-financial":[547,556,563,570,584,591],"support;":[548,557,564,571,585],"Gilead":[549],"Sciences:":[550],"Grants,":[552],"personal":[553,576],"Amplyx:":[558],"Merck:":[565],"Pfizer:":[572],"Grant":[574],"fees;":[577],"Astellas":[578],"Pharma:":[579],"F2G:":[586],"support.":[592],"Deeren:Alexion,":[593],"Amgen,":[594],"Janssen,":[595],"Roche,":[596],"Sunesis,":[597],"Takeda,":[598],"Sanofi:":[599],"Consultancy,":[600],"Honoraria,":[601],"Membership":[602],"entity's":[605],"Board":[606],"Directors":[608],"advisory":[610],"committees,":[611],"Research":[612],"Funding.":[613]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":14}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-12-05T00:00:00"}